Workflow
Quantitative analysis
icon
Search documents
Enphase Energy (ENPH) Has Just Flashed a 119% Payout Opportunity
Yahoo Finance· 2025-10-23 13:15
While the methodologies of fundamental and technical analysis represent the foundations of the financial publication industry, they’re not as effective in spotting objectively defined opportunities. Sometimes, these approaches are completely blind to favorable trading setups, a potential hole that quantitative analysis may address. Solar energy specialist Enphase Energy (ENPH) recently provided a clear example of this gap. As with other publicly traded companies, Enphase struggled during the midweek sessi ...
Driven To Perform: Top 3 Auto Stocks
Seeking Alpha· 2025-09-22 21:06
Core Insights - Steven Cress is a key figure in quantitative strategy and market data at Seeking Alpha, contributing to the development of the platform's quantitative stock rating system and analytical tools [1][2][3] - The Seeking Alpha Quant Rating system aims to interpret data for investors, providing insights that save time and enhance investment decision-making [1][2] - Cress has a strong background in investment research, having founded CressCap Investment Research and Cress Capital Management, and previously worked at Morgan Stanley and Northern Trust [3][4] Company Overview - Seeking Alpha has integrated Cress's expertise in quantitative analysis and market data, enhancing its offerings for investors [1][3] - The platform features a systematic stock recommendation tool called Alpha Picks, aimed at helping long-term investors build superior portfolios [1][2] Industry Context - The investment industry is increasingly leaning towards data-driven approaches to minimize emotional biases in decision-making, a trend that Cress actively promotes through his work [2][4] - With over 30 years of experience, Cress is well-equipped to address various investment topics, reflecting the growing importance of quantitative strategies in portfolio management [4]
RPAR: Tactical ETF With A Very Long-Term Strategy
Seeking Alpha· 2025-09-11 19:11
Group 1 - The article discusses Fred Piard, a quantitative analyst and IT professional with over 30 years of experience, who runs an investing group focused on quality dividend stocks and tech innovation companies [1] - Fred Piard has been investing in data-driven systematic strategies since 2010 and is the author of three books [1] Group 2 - The article does not provide any specific company or industry analysis, nor does it include financial data or performance metrics [2][3]
Power Solutions: Projected Growth Points To Further Upside
Seeking Alpha· 2025-07-21 11:24
Group 1 - Power Solutions (NASDAQ: PSIX) has experienced a significant increase in stock price this year, indicating strong market interest and potential growth [1] - The article will analyze the growth trend and valuation status of Power Solutions following the year-to-date price surge, highlighting its liquidity profile as a critical factor [1] - The investment strategy involves a data-driven approach that combines both technical and fundamental metrics to filter stocks, followed by in-depth research for final investment decisions [1] Group 2 - The selected portfolio aims to include a balanced mix of value and growth stocks to optimize total returns, with ongoing management through quantitative methods [1] - Continuous refinement of the investment strategy is emphasized through ongoing research and analysis to adapt to market changes [1]
X @mert | helius.dev
mert | helius.dev· 2025-06-25 16:08
great piece by my quantitative Katie Haun: https://t.co/hmma2QieIU ...
Novo Nordisk's Buy Scenario Is Supported By Quantitative Evidence
Seeking Alpha· 2025-05-28 11:42
Core Insights - Novo Nordisk was previously a leading player in the weight loss and diabetes drug markets but has experienced a significant decline in stock price from a peak of $148 in 2024 to its current level [1] Company Analysis - The decline in Novo Nordisk's stock price indicates potential challenges in maintaining its market dominance in the weight loss and diabetes sectors [1] Market Context - The performance of Novo Nordisk reflects broader trends in the pharmaceutical industry, particularly in the competitive landscape of diabetes and weight loss treatments [1]